Photoprotective behaviours in inflammatory bowel disease patients on azathioprine and TNF-α inhibitors

被引：0
|
作者：
Gallagher, C. [1 ,2 ]
Ridge, A. [3 ]
Tobin, A. M. [1 ,4 ]
Kevans, D. [5 ]
McNamara, D. [1 ,6 ]
机构：
[1] Adelaide & Meath Hosp, Dublin, Ireland
[2] Natl Childrens Hosp, Dept Clin Med, Dublin, Ireland
[3] Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland
[4] Natl Childrens Hosp, Dept Dermatol, Dublin, Ireland
[5] St James Hosp, Coll Dublin, Dept Gastroenterol, Dublin, Ireland
[6] Natl Childrens Hosp, Dept Clin Med & Gastroenterol, Dublin, Ireland
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P184
引用
收藏
页码：S169 / S170
页数：2
相关论文
共 50 条
  • [41] Long term efficacy of azathioprine monotherapy in patients with Inflammatory Bowel Disease
    Theodoraki, E.
    Papatzelou, I.
    Koutroubakis, I.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1444 - I1444
  • [42] Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease
    Marion, JF
    [J]. INFLAMMATORY BOWEL DISEASES, 1998, 4 (02) : 116 - 117
  • [43] Immunosuppressive drugs in inflammatory bowel disease: azathioprine
    Atreya, I.
    Neurath, M. F.
    [J]. IBD 2007 - ACHIEVEMENTS IN RESEARCH AND CLINICAL PRACTICE, 2008, 159 : 153 - 161
  • [44] Azathioprine: State of the art in inflammatory bowel disease
    Sandborn, WJ
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1998, 33 : 92 - 99
  • [45] Azathioprine dose escalation in inflammatory bowel disease
    Rayner, CK
    Hart, AL
    Hayward, CMM
    Emmanuel, AV
    Kamm, MA
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (01) : 65 - 71
  • [46] Azathioprine in inflammatory bowel disease, a safe alternative?
    Tanis, AA
    [J]. MEDIATORS OF INFLAMMATION, 1998, 7 (03) : 141 - 144
  • [47] TPMT in the treatment of inflammatory bowel disease with azathioprine
    Qasim, A
    Seery, J
    Buckley, M
    Morain, CO
    [J]. GUT, 2003, 52 (05) : 767 - 767
  • [48] Optimization of azathioprine dose in combined treatment with anti-TNF-alpha in inflammatory bowel disease
    Lucas Ramos, Javier
    Suarez Ferrer, Cristina
    Poza Cordon, Joaquin
    Sanchez Azofra, Maria
    Rueda Garcia, Jose Luis
    Martin Arranz, Eduardo
    Yebra Carmona, Jorge
    Andaluz Garcia, Irene
    Martin Arranz, Maria Dolores
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2021, 44 (05): : 337 - 345
  • [49] Rdp-58 -: Treatment of inflammatory bowel disease TNF-α production inhibitor
    Sorbera, LA
    [J]. DRUGS OF THE FUTURE, 2004, 29 (02) : 121 - 126
  • [50] Association of TNF-α-857C with inflammatory bowel disease in the Australian population
    O'Callaghan, NJ
    Adams, KE
    van Heel, DA
    Cavanaugh, JA
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (05) : 533 - 534
12345